AS A PHARMACIST, you'll hear about an advocacy group pushing for withdrawal of the gout med febuxostat ( Uloric, Xanthistop ) due to concerns it increases mortality. FDA adds Boxed Warning for increased risk of death with gout medicine Uloric (febuxostat), available at: https://www.fda.gov/drugs/drug-safety-and-availability/fda-adds-boxed-warning-increased-ri…
قراءة المزيدAs a pharmacist, you’ll get questions about managing chronic gout due to continued debate over whether to aim for a target uric acid level. We know to consider a chronic medication to lower uric acid when gout causes problems such as tophi or 2 or more acute gout flares/year. But there’s not much evidence on the best way to titrate medications. Some “treat to target”…
قراءة المزيدG out is one of the most common forms of arthritis. It occurs more often in men. During a gout attack, high uric acid levels lead to the formation of uric acid crystals in joints (usually knees, ankles, and feet; can affect elbows, wrists, and fingers). Symptoms can include pain, redness, joint swelling and limited range of motion, and fever. Gout risk factors inc…
قراءة المزيدNPS | Notes in Pharmacy Specialties is a free, open-access, peer-reviewed site focused on pharmacy practice. Articles are immediately accessible, covering clinical pharmacy, pharmaceutical care, health promotion, informatics, and more.
Egypt - Phone: (+20)1210274589
Gmail: abdelwahabward@gmail.com
Social Plugin